Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591913 | SCV000708057 | uncertain significance | not provided | 2017-04-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001854089 | SCV002136300 | uncertain significance | Cholestanol storage disease | 2022-07-04 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 182 of the CYP27A1 protein (p.Ile182Met). This variant is present in population databases (rs149366157, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with CYP27A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 501615). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CYP27A1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002532607 | SCV003649986 | uncertain significance | Inborn genetic diseases | 2021-11-19 | criteria provided, single submitter | clinical testing | The c.546T>G (p.I182M) alteration is located in exon 3 (coding exon 3) of the CYP27A1 gene. This alteration results from a T to G substitution at nucleotide position 546, causing the isoleucine (I) at amino acid position 182 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |